CNS PET ligand (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCNS PET ligand (Pfizer)
Drug Alias NamePF-0430-[18F][18F]-PF-0430
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionType 2 cyclic nucleotide phosphodiesterases modulatorsPositron-emission tomography enhancers
TargetsType 2 cyclic nucleotide phosphodiesterases
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Global Research and Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Global Research and Development
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A